EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Light-induced expression of gRNA allows for optogenetic gene editing of T lymphocytes in vivo

Diego Velasquez Pulgarin, Nathalie Pelo, Lin Ferrandiz, Tilen Tršelič, William A Nyberg, Gary Bowlin, Alexander Espinosa iD

Nucleic Acids Research · 2025

DOI: 10.1093/nar/gkaf213 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Nucleic Acids Research, 2025. Verfasst von Diego Velasquez Pulgarin und 6 weiteren Autor:innen. Beteiligte Einrichtung: Center for Molecular Medicine, Department of Medicine (K2), Karolinska Institutet, Karolinska University Hospital, 171 64 Stockholm, Sweden. Hauptthemen laut MEDLINE: Gene Editing, Optogenetics, RNA, Guide, CRISPR-Cas Systems, T-Lymphocytes. Die Arbeit wurde bisher 10-mal zitiert (Crossref) und nennt 29 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Cancerfonden, Whitaker Foundation, NIH HHS.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

There is currently a lack of tools capable of perturbing genes in both a precise and a spatiotemporal fashion. The flexibility of CRISPR (clustered regularly interspaced short palindromic repeats), coupled with light’s unparalleled spatiotemporal resolution deliverable from a controllable source, makes optogenetic CRISPR a well-suited solution for precise spatiotemporal gene perturbations. Here, we present a new optogenetic CRISPR tool (Blue Light-inducible Universal VPR-Improved Production of RGRs, BLU-VIPR) that diverges from prevailing split-Cas design strategies and instead focuses on optogenetic regulation of guide RNA (gRNA) production. We engineered BLU-VIPR around a new potent blue-light activated transcription factor (VPR-EL222) and ribozyme-flanked gRNA. The BLU-VIPR design is genetically encoded and ensures precise excision of multiple gRNAs from a single messenger RNA transcript. This simplified spatiotemporal gene perturbation and allowed for several types of optogenetic CRISPR, including indels, CRISPRa, and base editing. BLU-VIPR also worked in vivo with cells previously intractable to optogenetic gene editing, achieving optogenetic gene editing in T lymphocytes in vivo.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Gene EditingOptogeneticsRNA, Guide, CRISPR-Cas SystemsT-LymphocytesAnimalsCRISPR-Cas SystemsLightMiceHumansRNA, CatalyticTranscription FactorsHEK293 Cells

Substanzen

RNA, Guide, CRISPR-Cas SystemsRNA, CatalyticTranscription Factors

Autor:innen und Institutionen

  • Center for Molecular Medicine, Department of Medicine (K2), Karolinska Institutet, Karolinska University Hospital, 171 64 Stockholm, Sweden.
  • Department of Hematology, St Jude Children's Research Hospital, Memphis, TN 38105, United States.
  • Department of Medicine (H7), Karolinska Institutet, Karolinska University Hospital, 141 83 Huddinge, Sweden.
  • Department of Medicine, University of California, San Francisco, San Francisco, CA 94143, United States.
  • Department of Biomedical Engineering, University of Memphis, Memphis, TN 38152, United States.

ORCID-Profile: Alexander Espinosa

Förderung

  • Cancerfonden
  • Whitaker Foundation
  • NIH HHS
  • NIAMS NIH HHS
  • Konung Gustaf V:s och Drottning Victorias Frimurarestiftelse
  • National Institutes of Health

Zitieren

APA

Pulgarin, D. V., Pelo, N., Ferrandiz, L., Tršelič, T., Nyberg, W. A., Bowlin, G., & Espinosa, A. (2025). Light-induced expression of gRNA allows for optogenetic gene editing of T lymphocytes in vivo. Nucleic Acids Research. https://doi.org/10.1093/nar/gkaf213

Vancouver

Pulgarin DV, Pelo N, Ferrandiz L, Tršelič T, Nyberg WA, Bowlin G, et al. Light-induced expression of gRNA allows for optogenetic gene editing of T lymphocytes in vivo. Nucleic Acids Research. 2025. doi:10.1093/nar/gkaf213

BibTeX
@article{Pulgarin2025,
  author = {Pulgarin, Diego Velasquez and Pelo, Nathalie and Ferrandiz, Lin and Tršelič, Tilen and Nyberg, William A and Bowlin, Gary and Espinosa, Alexander},
  title = {Light-induced expression of gRNA allows for optogenetic gene editing of T lymphocytes in vivo},
  journal = {Nucleic Acids Research},
  year = {2025},
  doi = {10.1093/nar/gkaf213}
}
Kostenlos starten →